Skip to main content
graph.swiss
Abbott Laboratories

Abbott Laboratories

80.00 CHF+7.00 (+9.59%)
XSWX:ABTMarket Closed
ListedCHF127.2BHealthcareMedical Devices122,000 employees

Company Profile

Legal NameAbbott Laboratories
CEOMr. Robert B. Ford
Headquarters100 Abbott Park Road
Phone224 667 6100
Employees (FTE)122,000
SectorHealthcare
IndustryMedical Devices

Business Description

Abbott Laboratories is a diversified healthcare company that discovers, develops, manufactures, and sells a comprehensive range of medical products and pharmaceuticals globally. The company operates through four primary segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its medical device portfolio includes pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, and catheters designed to treat cardiovascular and neurological conditions. Abbott also produces continuous glucose monitors for diabetes management and diagnostic equipment including immunoassays and point-of-care testing kits. In nutrition, the company manufactures infant formula, adult nutritional liquids, and specialized dietary products for pediatric and adult populations. Abbott's established pharmaceutical segment offers branded generic medications across multiple therapeutic areas. With headquarters in Abbott Park, Illinois, and operations spanning more than 160 countries, Abbott derives approximately 60 percent of its sales from international markets, making it a truly global healthcare provider serving healthcare professionals, patients, and consumers worldwide.

Profitability & Growth

Profitability

Profit Margin+13.91%
Operating Margin+13.47%
Return on Equity (TTM)+12.33%
Return on Assets (TTM)+5.59%

Recent Year-End

Revenue36.49B
Revenue / Share25.91
Gross Profit20.62B
EBITDA11.78B
Diluted EPS3.17
Earnings Growth YoY-18.70%
Revenue Growth YoY+7.80%

Balance Sheet Snapshot

Total Cash (MRQ)

5.90B

Total Debt (MRQ)

27.60B

Current Ratio (MRQ)

1.39

Book Value / Share

24.11

Stock Statistics

Shares Outstanding1.74B
Float Shares1.73B
Avg Volume (10d)1
Avg Volume (90d)0
% Held by Insiders+0.49%
% Held by Institutions+82.48%

Valuation

Market Cap127.15B
Enterprise Value125.02B
Trailing P/E22.87
PEG Ratio-1.23
Price / Sales (TTM)2.80
Price / Book (MRQ)3.01
EV / Revenue3.43
EV / EBITDA13.17

Price Summary

52-Week Low65.00
52-Week High106.00
50-Day MA71.72
200-Day MA87.41
Beta0.61

Dividends

Forward Div Rate2.03
Forward Div Yield+2.79%
Trailing Div Rate2.00
5Y Avg Div Yield+191.00%
Payout Ratio+67.23%
Dividend Date2025-05-15
Ex-Dividend Date2026-07-15